Nama Insights

VanEck Biotech ETF (BBH)

Health · VanEck · NASDAQ

HealthETF
VanEck Biotech ETF (BBH) is an exchange-traded fund in the Health category. It has $469.37M in assets, an expense ratio of 0.35% and a 0.40% dividend yield. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Assets under management$469.37M
Expense ratio0.35%
CategoryHealth
Dividend yield0.40%
NAV$234.20
Fund familyVanEck
ExchangeNASDAQ

Top holdings

The largest positions VanEck Biotech ETF reports, by weight.

HoldingNameWeight
AMGN Amgen Inc 15.66%
GILD Gilead Sciences Inc 12.68%
VRTX Vertex Pharmaceuticals Inc 8.54%
REGN Regeneron Pharmaceuticals Inc 6.80%
MRNA Moderna Inc 5.70%
NTRA Natera Inc 5.08%
RVMD Revolution Medicines Inc Ordinary Shares 5.03%
IQV IQVIA Holdings Inc 5.02%
ARGX argenx SE ADR 4.72%
ILMN Illumina Inc 3.34%

Other Health ETFs

Explore live BBH data on Nama Insights →